CIK 0001831828
- Large accelerated filer
Vera Therapeutics, Inc.
Sign in to watch- Ticker
- VERA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812744449
- Phone
- +1 650-770-0077
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,334,142
- in 2 filings, $1.3M under 10b5-1 plans
Net −$1,334,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-13 | Curley Joanne Chief Development Officer | Sale | −11,733 | $18.28 | $214K | 26,821 |
| 2022-12-13 | Curley Joanne Chief Development Officer | Option exercise | +1,078 | $6.37 | $7K | 27,899 |
| 2022-12-13 | Curley Joanne Chief Development Officer | Sale | −1,078 | $18.19 | $20K | 26,821 |
| 2022-12-13 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −11,733 | 65,384 | ||
| 2022-12-13 | Curley Joanne Chief Development Officer | Option exercise · Stock Options (right to buy) | −1,078 | 8,639 | ||
| 2022-12-12 | Curley Joanne Chief Development Officer | Option exercise | +6,900 | $11.00 | $76K | 33,721 |
| 2022-12-12 | Curley Joanne Chief Development Officer | Sale | −6,900 | $18.25 | $126K | 26,821 |
| 2022-12-12 | Curley Joanne Chief Development Officer | Option exercise · Stock Options (right to buy) | −6,900 | 77,117 | ||
| 2022-12-07 | Curley Joanne Chief Development Officer | Sale | −494 | $16.47 | $8K | 26,821 |
| 2022-11-17 | Curley Joanne Chief Development Officer | Option exercise | +1,078 | $6.37 | $7K | 28,393 |
| 2022-11-17 | Curley Joanne Chief Development Officer | Sale | −1,078 | $15.86 | $17K | 27,315 |
| 2022-11-17 | Curley Joanne Chief Development Officer | Option exercise | +2,211 | $2.90 | $6K | 29,526 |
| 2022-11-17 | Curley Joanne Chief Development Officer | Sale | −2,211 | $15.84 | $35K | 27,315 |
| 2022-11-17 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −1,078 | 9,717 | ||
| 2022-11-17 | Curley Joanne Chief Development Officer | Option exercise · Stock Option (right to buy) | −2,211 | 38,013 | ||
| 2022-11-16 | Fordyce Marshall President and CEO | Option exercise | +5,153 | $2.32 | $12K | 186,303 |
| 2022-11-16 | Fordyce Marshall President and CEO | Option exercise | +60,000 | $2.90 | $174K | 246,303 |
| 2022-11-16 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −5,153 | 516 | ||
| 2022-11-16 | Fordyce Marshall President and CEO | Option exercise · Stock Option (Right to Buy) | −60,000 | 887,212 | ||
| 2022-11-09 | Curley Joanne Chief Development Officer | Sale | −494 | $16.54 | $8K | 27,315 |
Page 19 of 30 · 581 trades